Norges Bank’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-400,142
Closed -$3.4M 1978
2023
Q2
$3.4M Hold
400,142
﹤0.01% 1798
2023
Q1
$3.66M Hold
400,142
﹤0.01% 1833
2022
Q4
$4.57M Buy
400,142
+27,237
+7% +$404K ﹤0.01% 1807
2022
Q3
$6.35M Hold
372,905
﹤0.01% 1682
2022
Q2
$8.01M Buy
372,905
+279,784
+300% +$7.76M ﹤0.01% 1644
2022
Q1
$3.44M Buy
93,121
+11,002
+13% +$429K ﹤0.01% 1918
2021
Q4
$3.73M Buy
82,119
+9,665
+13% +$504K ﹤0.01% 1961
2021
Q3
$4.59M Sell
72,454
-143,323
-66% -$10.9M ﹤0.01% 1947
2021
Q2
$19.7M Sell
215,777
-147,294
-41% -$11.7M ﹤0.01% 1540
2021
Q1
$24.7M Buy
363,071
+345,067
+1,917% +$26.8M 0.01% 1412
2020
Q4
$1.3M Buy
+18,004
New +$1.04M ﹤0.01% 2000

Other funds holding CDNA

Norges Bank's CDNA Position: Q3 2023 in Review

Norges Bank sold out of CareDx (CDNA) in Q3 2023, closing a stake of 400,142 shares — an estimated $3.4M sold.

Norges Bank first reported a position in CDNA in Q4 2020 and held it in 11 quarters. The position peaked at $24.7M in Q1 2021. 150 funds tracked by Wall St. Rank hold CDNA as of Q3 2023.

  • Norges Bank reported no remaining CareDx position as of Q3 2023 after selling out during the quarter.
  • Norges Bank sold 400,142 CareDx shares in Q3 2023, an estimated $3.4M.
  • Norges Bank first reported a position in CareDx in Q4 2020 and held it in 11 quarters.
  • Norges Bank's CareDx position peaked at $24.7M in Q1 2021.
  • 150 funds tracked by Wall St. Rank held CareDx as of Q3 2023.

Based on Norges Bank's 13F filing for Q3 2023, filed 13 Nov 2023.